Michael Untch

机构：MSB Medical School Berlin, Koenig & Bauer (Germany), DRK Kliniken Berlin, Helios Kliniken, Helios Hospital Berlin-Buch · ORCID：0000-0002-1233-1267

发表论文 1411 篇 · 总被引 74898 次 · h-index 109

代表论文

• Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival (2025 · ESMO Open · 被引 36)
• Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ ERBB2 -Negative Early Breast Cancer (2025 · JAMA Oncology · 被引 21)
• Treatment of Patients with Early Breast Cancer (2025 · Geburtshilfe und Frauenheilkunde · 被引 8)
• Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials (2025 · The Lancet Oncology · 被引 6)
• 292MO Durvalumab in combination with neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Long-term analysis from the GeparNuevo trial (2025 · Annals of Oncology · 被引 5)
• Prevalence and prognosis of patients with breast cancer eligible for adjuvant abemaciclib or ribociclib: a nationwide population-based study (2025 · The Lancet Regional Health - Europe · 被引 1)